Table 1 Baseline characteristics between the survival group and death group
Variables | Total (N = 597) | Survival group (n = 505) | Death group (n = 92) | P value |
|---|---|---|---|---|
Demographics | ||||
Age, years | 53 (44, 62) | 51 (43, 62) | 58.5 (52, 65.5) | < 0.001 |
Gender, n (%) | 0.515 | |||
Male | 446 (74.71) | 180 (75.25) | 66 (71.74) | |
Female | 151 (25.29) | 125 (24.75) | 26 (28.26) | |
Smoke, n (%) | 239 (40.03) | 219 (43.37) | 20 (21.74) | < 0.001 |
Drink, n (%) | 95 (15.91) | 86 (17.03) | 9 (9.78) | 0.089 |
AAD type (Stanford classification), n (%) | < 0.001 | |||
Stanford type A | 365 (61.14) | 283 (56.04) | 82 (89.13) | |
Stanford type B | 232 (38.86) | 222 (43.96) | 10 (10.87) | |
History, n (%) | ||||
Diabetes mellitus | 28 (4.69) | 25 (4.95) | 3 (3.26) | 0.601 |
CKD | 14 (2.35) | 11 (2.18) | 3 (3.26) | 0.707 |
Hypertension | 485 (81.24) | 417 (82.57) | 68 (73.91) | 0.059 |
Heart failure | 11 (1.84) | 9 (1.78) | 2 (2.17) | 1.000 |
COPD | 17 (2.85) | 16 (3.17) | 1 (1.09) | 0.339 |
Vital signs | ||||
SBP, mmHg | 139 (123, 159) | 140 (125, 160) | 130 (110, 152.5) | 0.001 |
HR beats/min | 78 (68, 90) | 78 (69, 90) | 70 (63, 89) | 0.037 |
Surgery, n (% | 285 (47.74) | 273 (54.06) | 12 (13.04) | < 0.001 |
TEVAR, n (% | 142 (23.79) | 140 (27.72) | 2 (2.17) | < 0.001 |
Laboratory data | ||||
WBC, 109/L | 11.01 (8.32, 14.17) | 10.70 (8.09, 13.81) | 12.07 (9.68, 15.43) | < 0.001 |
Hemoglobin, g/L | 137 (124, 150) | 138 (126, 150) | 134 (119, 145.5) | 0.041 |
Platelets, 109/L | 185 (148, 232) | 192 (154, 239) | 160 (129, 198) | < 0.001 |
Neutrophil, 109/L | 9.18 (6.12, 12.38) | 8.90 (5.79, 12.05) | 10.74 (8.26, 14.14) | < 0.001 |
Lymphocyte, 109/L | 1.15 (0.76, 1.57) | 1.20 (0.79, 1.62) | 0.87 (0.64, 1.28) | < 0.001 |
Monocyte, 109/L | 0.58 (0.42, 0.81) | 0.57 (0.42, 0.79) | 0.64 (0.40, 0.91) | 0.216 |
NLR | 8.47 (4.37, 14.39) | 7.58 (3.99, 13.74) | 11.94 (8.31, 19.23) | < 0.001 |
MLR | 0.56 (0.35, 0.80) | 0.53 (0.33, 0.78) | 0.70 (0.54, 1.03) | < 0.001 |
SII | 1493.63 (873.71, 2515.58) | 1421.83 (847.63, 2389.66) | 1927.06 (1159.36, 3133.33) | 0.002 |
Echocardiography | ||||
Ascending aorta diameter, mm | 42 (37, 47) | 41 (36, 46) | 45 (41, 50) | < 0.001 |
LVEF, % | 60 (60, 63) | 60 (60, 63) | 60 (58.5, 63) | 0.200 |
Rupture of AD, n (%) | 35 (5.86) | 12 (2.38) | 23 (25.00) | < 0.001 |
AMI, n (%) | 14 (2.35) | 11 (2.18) | 3 (3.26) | 0.707 |
Stroke, n (%) | 17 (2.85) | 9 (1.78) | 8 (8.70) | 0.002 |
Massive pericardial effusion and tamponade, n (%) | 30 (5.03) | 2 (0.40) | 28 (30.43) | < 0.001 |